OverviewChartNewsTraderScreen

UC AKT.ANL. 12/24 SNW/  DE000HD1QPW3  /

gettex
2024-05-10  9:46:29 PM Chg.+0.280 Bid9:59:00 PM Ask9:59:00 PM Underlying Strike price Expiration date Option type
99.860EUR +0.28% 99.810
Bid Size: 50,000		 100.000
Ask Size: 50,000		 SANOFI SA INHABER ... 85.00 - 2024-12-31 Call
TeleTrader 05-10 Novavax skyrockets 213.5% in premarket, highest in 16 months
TeleTrader 05-10 Novavax soars 39.6% in premarket after Sanofi license deal
GlobeNewswire 05-10 Press Release: Sanofi and Novavax announce co-exclusive licensing agreement to co-commercialize COVI...
GlobeNewswire 05-09 Royalty Pharma to Acquire Royalty Interest in Sanofi’s Frexalimab
TeleTrader 05-09 Europe opens mixed with BoE in focus
GlobeNewswire 05-08 IGM Biosciences Announces First Quarter 2024 Financial Results and Provides Corporate Update
GlobeNewswire 05-07 Denali Therapeutics Reports First Quarter 2024 Financial Results and Business Highlights
GlobeNewswire 05-02 Regeneron Reports First Quarter 2024 Financial and Operating Results
GlobeNewswire 05-02 Press Release: Beyfortus real-world evidence published in The Lancet shows 82% reduction in infant R...
GlobeNewswire 04-30 Press Release: Annual General Meeting of April 30, 2024
TeleTrader 04-25 Europe opens mostly down after corporate earnings
TeleTrader 04-25 Europe down in premarket as financial results pour in
TeleTrader 04-25 Sanofi books net sales of €10.5B in Q1, up 2.4%
GlobeNewswire 04-25 Press Release: Sanofi Q1: robust 7% sales growth driven by launches, underpins full-year guidance
GlobeNewswire 04-23 Press Release: Rilzabrutinib LUNA 3 phase 3 study met primary endpoint in immune thrombocytopenia
GlobeNewswire 04-17 IGM Biosciences Announces Refocusing of Sanofi Collaboration
GlobeNewswire 04-17 Press Release: New 48-week frexalimab phase 2 data support potential for high sustained efficacy in ...
GlobeNewswire 04-16 2024 DTA Summit Agenda is LIVE!!
GlobeNewswire 04-10 Nurix Therapeutics Reports First Quarter Fiscal 2024 Financial Results and Provides a Corporate Upda...
GlobeNewswire 04-09 Nurix Therapeutics Announces Extension of Strategic Collaboration with Sanofi to Develop Novel Targe...
GlobeNewswire 03-29 Adagene Reports Full Year 2023 Financial Results and Provides Corporate Update
GlobeNewswire 03-22 Press Release: Availability of the Q1 2024 Memorandum for modelling purposes
GlobeNewswire 03-14 MeiraGTx Reports Fourth Quarter and Full Year 2023 Financial and Operational Results and Recent Busi...
GlobeNewswire 03-14 SMDG Announces Appointment of Industry Leader Dr. Zsuzsanna Devecseri to the Board of Directors
GlobeNewswire 03-11 Press Release: New Phase 2b results for amlitelimab support potential for best-in-class maintenance ...